Wenbin Yu
Papers
1
Total Citations
4
H-Index
1
About
Wenbin Yu is a leading surgical oncologist whose research focuses on optimizing perioperative care and improving clinical outcomes for patients with gastric cancer, particularly those undergoing advanced minimally invasive procedures. His major contributions center on the integration of neoadjuvant chemotherapy (NACT) with laparoscopic and robotic radical gastrectomy, addressing the complex challenges of managing advanced-stage disease. Notably, his work explores the role of perioperative probiotic supplements in enhancing short-term clinical outcomes, as detailed in his highly cited study protocol for the GISSG2023-01 multicenter randomized controlled trial. This protocol, which has already garnered 4 citations since its 2025 publication, demonstrates his commitment to rigorous, evidence-based surgical innovation. By systematically investigating how gut microbiota modulation can mitigate postoperative complications and improve recovery in patients receiving NACT, Yu is pioneering strategies to personalize and refine multimodal treatment pathways. His research not only advances the technical frontiers of gastric cancer surgery but also underscores the importance of holistic, patient-centered perioperative management, making him a key figure in the evolution of modern oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1